Request Demo
Last update 08 May 2025
GM-103
Last update 08 May 2025
Overview
Basic Info
Drug Type Oncolytic virus |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with GM-103NCT06265025
A Phase I/II, Open-label, Dose-escalation With Expansion Study of GM103 Via Intratumoral Injection, Alone and in Combination With Pembrolizumab in Adult Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
100 Clinical Results associated with GM-103
Login to view more data
100 Translational Medicine associated with GM-103
Login to view more data
100 Patents (Medical) associated with GM-103
Login to view more data
100 Deals associated with GM-103
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 2 | South Korea | 20 Feb 2024 | |
| Colorectal Cancer | Phase 2 | South Korea | 20 Feb 2024 | |
| Head and Neck Neoplasms | Phase 2 | South Korea | 20 Feb 2024 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | South Korea | 20 Feb 2024 | |
| Melanoma | Phase 2 | South Korea | 20 Feb 2024 | |
| Renal Cell Carcinoma | Phase 2 | South Korea | 20 Feb 2024 | |
| Uterine Cervical Cancer | Phase 2 | South Korea | 20 Feb 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free